Q4 2023 Holdings
Filed 2024-02-13 | 21 holdings | $359.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| NU Hldgs LTD(NU) | ORD SHS CL A | G6683N103 | $76.3M | 9,155,661 | 21.2% |
| Doordash Inc(DASH) | CL A | 25809K105 | $59.7M | 603,288 | 16.6% |
| Uipath Inc(PATH) | CL A | 90364P105 | $57.2M | 2,303,452 | 15.9% |
| Rayzebio, Inc. | COM | 75525N107 | $48.4M | 778,922 | 13.5% |
| Snowflake Inc(SNOW) | CL A | 833445109 | $43.0M | 215,843 | 11.9% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $27.0M | 481,770 | 7.5% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $13.1M | 3,417,075 | 3.7% |
| Klaviyo Inc(KVYO) | COM SER A | 49845K101 | $13.1M | 471,260 | 3.6% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $8.1M | 1,652,605 | 2.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $5.3M | 260,000 | 1.5% |
| 908 Devices Inc(MASS) | COM | 65443P102 | $2.7M | 237,258 | 0.7% |
| Spruce Biosciences Inc | COM | 85209E109 | $2.3M | 787,007 | 0.6% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $1.3M | 724,873 | 0.4% |
| Candel Therapeutics Inc(CADL) | COM | 137404109 | $1.2M | 811,737 | 0.3% |
| Absci Corporation(ABSI) | COM | 00091E109 | $242.8K | 57,804 | 0.1% |
| Coupang Inc(CPNG) | CL A | 22266T109 | $169.2K | 10,451 | 0.0% |
| Toast Inc(TOST) | CL A | 888787108 | $143.6K | 7,865 | 0.0% |
| Datadog Inc(DDOG) | CL A COM | 23804L103 | $123.2K | 1,015 | 0.0% |
| Samsara Inc(IOT) | COM CL A | 79589L106 | $119.2K | 3,570 | 0.0% |
| Crowdstrike Hldgs Inc(CRWD) | CL A | 22788C105 | $87.8K | 344 | 0.0% |
| Gitlab Inc(GTLB) | CLASS A COM | 37637K108 | $41.4K | 658 | 0.0% |